Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - By Product (Instruments, Consumables, Accessories, and Software), Application (Cancer Diagnosis, Genetic Disease Diagnosis, Infectious Disease Diagnostic, and Others), and End User (Diagnostic Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnological Companies, and Others)


No. of Pages: 106    |    Report Code: BMIRE00029253    |    Category: Life Sciences

Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
Buy Now

The Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is expected to grow from US$ 217.6 million in 2022 to US$ 400.9 million by 2030. It is estimated to grow at a CAGR of 7.9% from 2022 to 2030.

Increasing R&D Investments in In-Vitro Diagnostics Fuel Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market

The Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is driven by continued investments in research and development (R&D) activities related to in-vitro diagnostics (IVD). With its unique capability to visualize specific DNA sequences within cellular environments, the FISH technique has emerged as a key procedure in the modern diagnostics ecosystem, particularly in detecting genetic disorders and rare diseases. An upsurge in R&D funding in IVD has catalyzed transformative advancements in FISH imaging systems by allowing researchers to create cutting-edge platforms providing enhanced image quality with features supporting streamlined automation, culminating in more accurate and rapid diagnostic processes. PNA FISH, a novel diagnostic method that uses FISH with peptide nucleic acid (PNA) probes, combines the ease of traditional staining procedures with the exceptional performance of PNA probes to provide rapid and accurate diagnoses of contagious diseases, which makes PNA FISH suitable for routine application and enables clinical microbiology laboratories to report important information for patient therapy within a time frame that is not possible using classic biochemical methods.

Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Overview

The Asia Pacific Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is expected to register the highest CAGR during the forecast period. The regional market is expected to grow rapidly in the coming years due to factors such as high cancer prevalence rates in countries, government initiatives to improve the medical device industry, and robust medical device manufacturing. Delivery centers in Indonesia, India, and China typically support outsourcing services in this region. Additionally, the rising cases of genetic disorders and infectious diseases significantly expand the Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market growth in Asia Pacific.

Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Segmentation 

The Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented into product, application, end users and country.

Based on product, the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented into instruments, consumables, accessories, and software. The consumables segment held the largest share of the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

In terms of application, the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnostic, and others. The cancer diagnosis segment held the largest share of the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

Based on end user, the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented into diagnostic laboratories, contract research organizations, pharmaceutical and biotechnological companies, and others. The diagnostic laboratories segment held the largest share of the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

By country, the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The China dominated the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

Euroclone SpA, Tissuegnostics Gmbh, Agilent Technologies Inc, Abnova Taiwan Corp, Biogenex Laboratories Inc, Leica Biosystems Nussloch Gmbh, Metasystems Probes Gmbh, Bio-View Ltd, And Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market.    


Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Strategic Insights

Strategic insights for the Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/asia-pacific-fluorescence-in-situ-hybridization-fish-imaging-systems-market-strategic-framework.webp
Get more information on this report

Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Report Scope

Report Attribute Details
Market size in 2022 US$ 217.6 Million
Market Size by 2030 US$ 400.9 Million
Global CAGR (2022 - 2030) 7.9%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Product
  • Instruments
  • Consumables
  • Accessories
  • Software
By Application
  • Cancer Diagnosis
  • Genetic Disease Diagnosis
  • Infectious Disease Diagnostic
By End User
  • Diagnostic Laboratories
  • Contract Research Organizations
  • Pharmaceutical and Biotechnological Companies
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Euroclone SpA
  • TissueGnostics GmbH
  • Agilent Technologies Inc
  • Abnova Taiwan Corp
  • BioGenex Laboratories Inc
  • Leica Biosystems Nussloch GmbH
  • MetaSystems Probes GmbH
  • Bio-View Ltd
  • Thermo Fisher Scientific Inc
  • Applied Spectral Imaging
  • Get more information on this report

    Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Regional Insights

    The geographic scope of the Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/asia-pacific-fluorescence-in-situ-hybridization-fish-imaging-systems-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market

    • Euroclone SpA
    • TissueGnostics GmbH
    • Agilent Technologies Inc
    • Abnova Taiwan Corp
    • BioGenex Laboratories Inc
    • Leica Biosystems Nussloch GmbH
    • MetaSystems Probes GmbH
    • Bio-View Ltd
    • Thermo Fisher Scientific Inc
    • Applied Spectral Imaging
    Frequently Asked Questions
    How big is the Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market?

    The Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is valued at US$ 217.6 Million in 2022, it is projected to reach US$ 400.9 Million by 2030.

    What is the CAGR for Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market by (2022 - 2030)?

    As per our report Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, the market size is valued at US$ 217.6 Million in 2022, projecting it to reach US$ 400.9 Million by 2030. This translates to a CAGR of approximately 7.9% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market report typically cover these key segments-

    • Product (Instruments, Consumables, Accessories, Software)
    • Application (Cancer Diagnosis, Genetic Disease Diagnosis, Infectious Disease Diagnostic)
    • End User (Diagnostic Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnological Companies)

    What is the historic period, base year, and forecast period taken for Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market?

    The Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Euroclone SpA
  • TissueGnostics GmbH
  • Agilent Technologies Inc
  • Abnova Taiwan Corp
  • BioGenex Laboratories Inc
  • Leica Biosystems Nussloch GmbH
  • MetaSystems Probes GmbH
  • Bio-View Ltd
  • Thermo Fisher Scientific Inc
  • Applied Spectral Imaging
  • Who should buy this report?

    The Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now